Compound of formula (I) or an agronomically acceptable salt thereof: (I) wherein the substituents are as defined in claim 1, useful as a pesticides, especially as herbicides.

##STR00001##

Compound of formula (I) or an agronomically acceptable salt thereof: (I) wherein the substituents are as defined in claim 1, useful as a pesticides, especially as herbicides.

##STR00001##

Compound of formula (I) or an agronomically acceptable salt thereof, wherein the substituents are as defined in claim 1, useful as a pesticides, especially as herbicides.

##STR00001##

Compound of formula (I) or an agronomically acceptable salt thereof, wherein the substituents are as defined in claim 1, useful as a pesticides, especially as herbicides.

##STR00001##

The present invention provides NOS inhibitors such as iNOS inhibitors, or a pharmaceutically acceptable salt, ester, prodrug, complex, solvate, hydrate, or isomer thereof, in any crystalline form or in amorphous form. The inhibitors include 1,1 or 1,2 substituted-ethyl carbamimido thioates, cyclic compounds substituted with a carbamimidoyl sulfanylethylphenyl group and a carbamimidoylsulfanyl group, compounds substituted with a carbamimidoyl sulfanylethyl phenylmethyl group, bis-carbamimidoylsulfanylethyl substituted compounds, 2-propoxypyridine derivatives, alkylamine or heteroalkylamine derivatives, n-aminoethyl n-phenyl amine derivatives, and saturated heterocyclic fused benzene derivatives. Pharmaceutical products comprising the NOS inhibitors such as iNOS inhibitors and the applications thereof in prophylaxis and/or treatment of inflammatory diseases, and proliferative diseases such as cancer including gastro-intestinal, colorectal, gynecological, pancreatic, head and neck, esophageal, breast, lung, and central nervous system tumors, among others, are also provided.

The present invention provides NOS inhibitors such as iNOS inhibitors, or a pharmaceutically acceptable salt, ester, prodrug, complex, solvate, hydrate, or isomer thereof, in any crystalline form or in amorphous form. The inhibitors include 1,1 or 1,2 substituted-ethyl carbamimido thioates, cyclic compounds substituted with a carbamimidoyl sulfanylethylphenyl group and a carbamimidoylsulfanyl group, compounds substituted with a carbamimidoyl sulfanylethyl phenylmethyl group, bis-carbamimidoylsulfanylethyl substituted compounds, 2-propoxypyridine derivatives, alkylamine or heteroalkylamine derivatives, n-aminoethyl n-phenyl amine derivatives, and saturated heterocyclic fused benzene derivatives. Pharmaceutical products comprising the NOS inhibitors such as iNOS inhibitors and the applications thereof in prophylaxis and/or treatment of inflammatory diseases, and proliferative diseases such as cancer including gastro-intestinal, colorectal, gynecological, pancreatic, head and neck, esophageal, breast, lung, and central nervous system tumors, among others, are also provided.

The present invention discloses a triazine benzoate compound having the structure shown in formula (I) or a stereoisomer: ##STR00001## The definition of each substituent in the formula I is described in the description. The compound of the formula I of the present invention has excellent herbicidal activity and can be used for controlling weeds.

The present invention discloses a triazine benzoate compound having the structure shown in formula (I) or a stereoisomer: ##STR00001## The definition of each substituent in the formula I is described in the description. The compound of the formula I of the present invention has excellent herbicidal activity and can be used for controlling weeds.